We are live on ! Find out more
PVLA

Palvella Therapeutics
PVLA

97 hedge funds and large institutions have $129M invested in Palvella Therapeutics in 2019 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 27 increasing their positions, 29 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

33% more capital invested

Capital invested by funds: $96.9M → $129M (+$31.7M)

0.09% more ownership

Funds ownership: 0.72% → 0.81% (+0.09%)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

4% less first-time investments, than exits

New positions opened: 23 | Existing positions closed: 24

7% less repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 29

1% less funds holding

Funds holding: 98 → 97 (-1)

Holders
97
Holders Change
-1
Holders Change %
-1.02%
% of All Funds
1.91%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
23
Increased
27
Reduced
29
Closed
24
Calls
$107K
Puts
–
Net Calls
+$107K
Net Calls Change
-$281K

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$8.79M
2
ACM
Aquilo Capital Management
California
+$6.96M
3
Citadel Advisors
Citadel Advisors
Florida
+$3.65M
4
CS
Candriam SCA
Luxembourg
+$2.87M
5
SB
Samsara BioCapital
California
+$2.44M

Top Sellers

Rank Fund Capital Flow
1
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$4.45M
2
SSA
Schonfeld Strategic Advisors
New York
-$1.08M
3
Renaissance Technologies
Renaissance Technologies
New York
-$711K
4
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$703K
5
Invesco
Invesco
Georgia
-$513K
Name Holding Trade Value Shares
Change 		Change in
Stake
FDCDDQ
26
Federation des caisses Desjardins du Quebec
Quebec, Canada
$719K – – –
GCP
27
GSA Capital Partners
United Kingdom
$707K +$677K +2,442 New
MWNA
28
Marshall Wace North America
New York
$701K +$671K +2,422 New
Cerity Partners
29
Cerity Partners
New York
$689K – – –
VC
30
Voss Capital
Texas
$543K +$520K +1,875 New
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$540K -$703K -2,535 -58%
SO
32
STRS Ohio
Ohio
$506K +$119K +430 +33%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$484K +$39.4K +142 +9%
PAM
34
Panagora Asset Management
Massachusetts
$463K +$443K +1,598 New
Deutsche Bank
35
Deutsche Bank
Germany
$443K +$371K +1,338 +683%
Charles Schwab
36
Charles Schwab
California
$420K – – –
Two Sigma Investments
37
Two Sigma Investments
New York
$411K +$393K +1,419 New
Two Sigma Advisers
38
Two Sigma Advisers
New York
$392K -$28.6K -103 -7%
Wells Fargo
39
Wells Fargo
California
$334K +$277 +1 +0.1%
Creative Planning
40
Creative Planning
Kansas
$329K -$17.2K -62 -5%
6CM
41
683 Capital Management
New York
$326K -$209K -753 -40%
Massachusetts Financial Services
42
Massachusetts Financial Services
Massachusetts
$313K -$32.4K -117 -10%
SIM
43
Spark Investment Management
New York
$302K -$113K -406 -28%
RCG
44
Rock Creek Group
District of Columbia
$290K +$69.3K +250 +33%
GGHC
45
Gilder Gagnon Howe & Co
New York
$269K +$258K +930 New
State of Wisconsin Investment Board
46
State of Wisconsin Investment Board
Wisconsin
$258K – – –
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$254K -$3.33K -12 -1%
RJA
48
Raymond James & Associates
Florida
$247K – – –
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$229K +$1.11K +4 +0.5%
Ohio Public Employees Retirement System (OPERS)
50
Ohio Public Employees Retirement System (OPERS)
Ohio
$217K +$208K +750 New
1
2
3 4 5

PVLA Hedge Fund Activity: Q4 2019 in Review

97 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Palvella Therapeutics (PVLA) for Q4 2019, worth a combined $129M — up 33% from $96.9M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of PVLA and 23 opened new positions — a net loss of 1 holder — while 29 trimmed existing stakes and 27 added.

The largest buyer was EcoR1 Capital, opening a new position worth an estimated $8.79M. The largest seller was Acadian Asset Management, cutting an estimated $4.45M.

  • 97 institutional investors held Palvella Therapeutics (PVLA) as of Q4 2019, down from 98 in Q3 2019.
  • Funds reported $129M of Palvella Therapeutics stock for Q4 2019, up 33% quarter-over-quarter.
  • 23 funds opened new Palvella Therapeutics positions in Q4 2019 and 24 closed out, a net change of -1 holder.
  • The largest Palvella Therapeutics buyer in Q4 2019 was EcoR1 Capital, an estimated $8.79M added.
  • The largest Palvella Therapeutics seller in Q4 2019 was Acadian Asset Management, an estimated $4.45M sold.

Based on aggregated 13F filings for Q4 2019.